Sign in to follow
Search Results

0 results for 'Merck'

You can use to get even better search results
October 24, 2017 | The Recorder

Four Changes to Patent Litigation Post-'TC Heartland'

The Supreme Court's recent TC Heartland v. Kraft Foods Group Brands opinion is relatively simple to understand—the word “resides” in the patent venue statute (28 U.S.C. Section 1400) refers to the state where an accused infringer is incorporated. TC Heartland's ramifications, however, may be dramatic.
17 minute read
August 15, 2017 | The American Lawyer

Big Law Responds to Trump's Charlottesville Protest Remarks

In the days following the violent clashes between rival groups of protesters in Charlottesville, Virginia, that killed a 32-year-old legal assistant, some corporate executives have openly criticized President Donald Trump for his delay in condemning white supremacists. Some Big Law leaders have reacted to the president's response.
31 minute read
December 29, 2016 |

2016 in Review: Litigators of the Week, Take a Bow

A look back at the Litigator of the Week winners in 2016, including the firms and lawyers that racked up the most honors.
207 minute read
December 22, 2016 |

Litigator of the Week: The Biggest Patent Verdict in U.S. History--By a Lawyer Who Never Tried an IP Case Before

Don't hate her -- but Jones Day partner Stephanie Parker had never tried an IP case before she convinced a jury to award her client, a Merck subsidiary, $2.54 billion in a patent infringement suit against Gilead Sciences.
20 minute read
December 22, 2016 |

Tips From Star Litigators

How to succeed with judges and juries.
27 minute read
December 05, 2016 |

What These Winning Litigators Know That You Might Not

When 23 of the top litigators in the country offer advice on how to succeed in court, it's worth listening.
41 minute read
September 26, 2016 |

Women Leaders in Tech Law: Fish & Richardson's Juanita Brooks

Juanita Brooks won a post-trial ruling from a federal judge in San Jose in June that wiped out a $200 million damages award against client Gilead Sciences Inc. in a patent case against rival Abbott Laboratories that targeted Gilead's blockbuster hepatitis C drugs, Sovaldi and Harvoni.
5 minute read
June 09, 2016 |

Litigator of the Week: Jonathan Singer of Fish & Richardson

When a Merck & Co. in-house attorney recanted his deposition testimony in a patent brawl over Hepatitis C medications, Fish & Richardson lawyers knew they had an opening. Jonathan Singer used it to get a $200 million verdict thrown out.
11 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources